piperidine has been researched along with Cholestasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alper, PB; Bao, D; Bursulaya, B; Chianelli, D; Groessl, T; Joseph, SB; Kim, Y; Laffitte, B; Liu, B; McNamara, P; Molteni, V; Mutnick, D; Phimister, A; Rucker, PV; Schmeits, J; Seidel, HM; Tully, DC; Vidal, A; Williams, J; Wu, X; Zoll, J | 1 |
1 other study(ies) available for piperidine and Cholestasis
Article | Year |
---|---|
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
Topics: Administration, Oral; Animals; Benzothiazoles; Biological Availability; Cholestasis; Dogs; Drug Evaluation, Preclinical; Fibroblast Growth Factors; Gene Expression Regulation; Humans; Isoxazoles; Male; Microsomes, Liver; Non-alcoholic Fatty Liver Disease; Piperidines; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Triglycerides | 2017 |